Filtered By:
Management: WHO
Vaccination: Ebola Vaccine
This page shows you your search results in order of date.
Order by Relevance | Date
Total 68 results found since Jan 2013.
Exclusion of pregnant people from emergency vaccine clinical trials: A systematic review of clinical trial protocols and reporting from 2009 to 2019
CONCLUSION: Pregnant people are underrepresented in vaccine clinical trials conducted during outbreaks, resulting in underreporting of pregnancy-related outcomes and a lack of protection for pregnant people and neonates from infectious diseases.PMID:37442686 | DOI:10.1016/j.vaccine.2023.06.073
Source: Vaccine - July 13, 2023 Category: Allergy & Immunology Authors: Jamie Minchin Gavin H Harris Sasha Baumann Emily R Smith Source Type: research
The U.S. Scientist At the Heart of COVID-19 Lab Leak Conspiracies Is Still Trying to Save the World From the Next Pandemic
Ralph Baric stepped onto the auditorium stage at the University of North Carolina, Chapel Hill, and looked out at the sparse audience that had come to hear him speak. On the large projector screen hanging behind him, the following words appeared: How Bad the Next Pandemic Could Be, What Might It Look Like, and Will We be Ready. The date was May 29, 2018.
“Well, I have to admit I’m a little worried about giving this talk,” Baric said. “The reason is being labelled a harbinger of doom.” The screen shifted, and images of the four horsemen of the apocalypse—Death, Famine, War, and Plague&mda...
Source: TIME: Health - July 11, 2023 Category: Consumer Health News Authors: Dan Werb Tags: Uncategorized COVID-19 feature freelance Source Type: news
Uganda Reports Worrisome Increase in Ebola Cases in Capital
KAMPALA, Uganda — Ugandan officials have reported 11 more cases of Ebola in the capital since Friday, a worrisome increase in infections just over a month after an outbreak was declared in a remote part of the East African country.
Nine more people in the Kampala metropolitan area tested positive for Ebola on Sunday, in addition to two others on Friday, Health Minister Jane Ruth Aceng said Monday.
A top World Health Organization official in Africa said last week that Uganda’s Ebola outbreak was “rapidly evolving,” describing a challenging situation for health workers.
Ugandan health authorities have...
Source: TIME: Health - October 20, 2022 Category: Consumer Health News Authors: Rodney Muhumuza/AP Tags: Uncategorized Disease healthscienceclimate wire Source Type: news
Viral vector and nucleic acid vaccines against COVID-19: A narrative review
After about 2 years since the first detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in Wuhan, China, in December 2019 that resulted in a worldwide pandemic, 6.2 million deaths have been recorded. As a result, there is an urgent need for the development of a safe and effective vaccine for coronavirus disease 2019 (COVID-19). Endeavors for the production of effective vaccines inexhaustibly are continuing. At present according to the World Health Organization (WHO) COVID-19 vaccine tracker and landscape, 153 vaccine candidates are developing in the clinical phase all over the world. Some n...
Source: Frontiers in Microbiology - August 31, 2022 Category: Microbiology Source Type: research
The Virus Hunters Trying to Prevent the Next Pandemic
Nobody saw SARS-CoV-2 coming. In the early days of the pandemic, researchers were scrambling to collect samples from people who had mysteriously developed fevers, coughs, and breathing problems. Pretty soon, they realized that the disease-causing culprit was a new virus humans hadn’t seen before.
And the world, lacking a coordinated global response, was unprepared. Some countries acted quickly to develop tests for the novel coronavirus, while others with fewer resources were left behind. With a virus oblivious to national borders, and with travel between countries and continents more common than it had been in previo...
Source: TIME: Health - August 1, 2022 Category: Consumer Health News Authors: Alice Park and Video by Andrew D. Johnson Tags: Uncategorized Disease Frontiers of Medicine 2022 healthscienceclimate Source Type: news
Monkeypox Is Not a Global Emergency ‘At This Stage,’ WHO Says
(London) — The World Health Organization (WHO) said the escalating monkeypox outbreak in more than 50 countries should be closely monitored but does not warrant being declared a global health emergency.
In a statement Saturday, a WHO emergency committee said many aspects of the outbreak were “unusual” and acknowledged that monkeypox—which is endemic in some African countries—has been neglected for years.
“While a few members expressed differing views, the committee resolved by consensus to advise the WHO director-general that at this stage the outbreak should be determined to not constit...
Source: TIME: Health - June 27, 2022 Category: Consumer Health News Authors: Maria Cheng / AP Tags: Uncategorized healthscienceclimate Public Health wire Source Type: news
Antimicrobial Resistance Calls for Brainpower of a Space Agency and Campaigning Zeal of an NGO
This article is republished from The Conversation under a Creative Commons license. Read the original article.
Source: IPS Inter Press Service - Health - November 17, 2021 Category: International Medicine & Public Health Authors: External Source Tags: Global Headlines Health Source Type: news
Positive New Data for Johnson & Johnson Single-Shot COVID-19 Vaccine on Activity Against Delta Variant and Long-lasting Durability of Response
NEW BRUNSWICK, N.J., July 1, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced data that demonstrated its single-shot COVID-19 vaccine generated strong, persistent activity against the rapidly spreading Delta variant and other highly prevalent SARS-CoV-2 viral variants. In addition, the data showed that the durability of the immune response lasted through at least eight months, the length of time evaluated to date. The two preprint study summaries have been submitted today to bioRxiv. “Today’s newly announced studies reinforce the ability of the Johnson & Johnson COVID-19 vaccine to help prot...
Source: Johnson and Johnson - July 1, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news
Equitable and Feasible Distribution of SARS-CoV-2 Vaccines for All in Africa
Am J Trop Med Hyg. 2021 Jun 28:tpmd210264. doi: 10.4269/ajtmh.21-0264. Online ahead of print.ABSTRACTAs the fight against the coronavirus disease 2019 (COVID-19) pandemic continues, the necessity for wide-scale, global vaccine rollout to reduce the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and slow its mutation rate remains unassailable. The COVID-19 Vaccines Global Access (COVAX) initiative's campaign involves a proportional framework to finance and distribute SARS-CoV-2 vaccines in low- and middle-income countries. However, the COVAX framework has critical limitations, including limited fundi...
Source: Am J Trop Med Hyg - June 28, 2021 Category: Infectious Diseases Authors: Abu Bakarr Rogers Mohamed Bailor Barrie Mosoka P Fallah J Daniel Kelly Source Type: research
